Marcel Walser, PhD

Senior Director at Molecular Partners AG

Speaker

Marcel received his MSc in molecular biology and developed novel screening methods for biotechnological applications during his PhD, both at the ETH Zurich, Switzerland. He joined Molecular Partners in 2011. Since then, he led several activities within the Lead Generation Department to enable developable DARPin candidates for various therapeutic programs. During the pandemic, Marcel initiated and lead the pre-clinical activities to generate a clinical DARPin antiviral against SARS-CoV-2. As a co-inventor of the DARPin Switch technology, Marcel is currently driving activities to develop immuno-oncology candidates which are conditionally activated upon antigen binding in the tumor microenvironment.